Sefoksitin etkileşimleri

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (Ertapenem etiketi, Kontrendikasyonlar)

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (İmipenem ve silastatin etiketi, Uyarılar ve önlemler)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Aminoglycosides: Increased potential of nephrotoxicity. (Sefoksitin etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (Etakrinik asit etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (Furosemid etiketi, İlaç etkileşimleri)

Aminoglycosides: Increased potential of nephrotoxicity. (Sefoksitin etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (Mikofenolat etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Aminoglycosides: Increased potential of nephrotoxicity. (Sefoksitin etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Aminoglycosides: Increased potential of nephrotoxicity. (Sefoksitin etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Probenesid etiketi, İlaç etkileşimleri)

DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Probenesid ve kolşisin etiketi, İlaç etkileşimleri)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (Protamin etiketi, Önlemler)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Aminoglycosides: Increased potential of nephrotoxicity. (Sefoksitin etiketi, İlaç etkileşimleri)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Sefoksitin etiketi, Uyarılar ve önlemler)

Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (Meropenem etiketi, Uyarılar ve önlemler)